Here are five updates from gastroenterology companies and practices from the past week:
The FDA sent Takeda a questioning letter in response to the company's biologics license application concerning the subcutaneous formulation of Entyvio, a maintenance therapy for ulcerative colitis.
Baptist Medical Center in Jacksonville, Fla., built what it believes to be the region's first gastroesophageal reflux center.
South Denver Gastroenterology opened a clinic and endoscopy center in Castle Rock, Colo.
Conmed is leaving the NASDAQ and transferring its listing to the New York Stock Exchange.
Minneapolis-based Colon & Rectal Surgery Associates will join Infinite Health Collaborative in the spring.